ABSI stock

Absci Corp (ABSI) stock forecast · rev $533.0K

Absci Corp (ABSI) is a biotechnology company listed on NASDAQ.

This ABSI forecast page states what the cached financials imply — not a price target and not a guarantee. Absci Corp outlooks on Lician start from reported revenue and the latest filing, then you decide.

Latest reported ABSI revenue for 2026-06-30 was $533.0K. Net income was -$62.8M. ABSI currently screens at market cap $1.13B.

Period-over-period revenue change is not in cache for ABSI, so this page does not invent a growth rate.

ABSI currently screens at market cap $1.13B. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.

When the next ABSI 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.

Not a prediction market. For the live quote and the full model, use the ABSI stock page.

Not investment advice.

Full ABSI analysis